VCYT peer analysis
Veracyte (VCYT) against its competitors: price, today's move, 1-year return and market value side by side.
- VCYT's peers: BDSX (Biodesix), BIAF (bioAffinity Technologies), BLLN (BillionToOne), CSTL (Castle Biosciences), GH (Guardant Health), IMDX (Insight Molecular Diagnostics), MYGN (Myriad Genetics), NEO (NeoGenomics).
VCYT and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BDSX Biodesix | $7.56 | -8.92% | 9.57% | $83.83M |
| BIAF bioAffinity Technologies | $1.85 | -13.95% | -91.61% | $11.62M |
| BLLN BillionToOne | $89.92 | -0.31% | -7.67% | $4.30B |
| CSTL Castle Biosciences | $32.86 | -1.63% | -5.17% | $1.01B |
| GH Guardant Health | $145.83 | 0.16% | 46.49% | $19.73B |
| IMDX Insight Molecular Diagnostics | $1.66 | 4.40% | -72.33% | $54.38M |
| MYGN Myriad Genetics | $5.36 | -3.25% | -16.77% | $514.14M |
| NEO NeoGenomics | $14.79 | -1.99% | 43.87% | $1.93B |
| PSNL Personalis | $14.01 | -4.82% | 70.02% | $1.52B |
| WGS GeneDx | $46.35 | -5.87% | -65.31% | $1.39B |
| VCYT Veracyte | $25.18 | 0.56% | -36.94% | $2.03B |